(Q36197922)

12 August 2017

1 reference

title

Development of 17alpha-estradiol as a neuroprotective therapeutic agent: rationale and results from a phase I clinical study (English)

1 reference

12 August 2017

James A Dykens

1

1 reference

12 August 2017

Walter H Moos

series ordinal

2

1 reference

12 August 2017

Neil Howell

series ordinal

3

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

Annals of the New York Academy of Sciences

12 August 2017

published in

1 reference

12 August 2017

volume

1052

1 reference

12 August 2017

page(s)

116-135

1 reference

Cognitive function in nondemented older women who took estrogen after menopause.

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1347.008

The role of estrogen in the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1347.008

Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1347.008

High-dose estradiol improves cognition for women with AD: results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1347.008

Anti-oxidative neuroprotection by estrogens in mouse cortical cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1347.008

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1347.008

1 reference

12 August 2017

1 reference